Anzeige
Mehr »
Dienstag, 22.07.2025 - Börsentäglich über 12.000 News
100% seit April - und trotzdem erst der Anfang? Kupfer wird zum Turbo-Rohstoff des Jahres!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DJ5B | ISIN: IE00BDGMC594 | Ticker-Symbol: AWK
Tradegate
18.07.25 | 15:15
9,500 Euro
+1,06 % +0,100
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
AVADEL PHARMACEUTICALS PLC Chart 1 Jahr
5-Tage-Chart
AVADEL PHARMACEUTICALS PLC 5-Tage-Chart
RealtimeGeldBriefZeit
9,2509,50011:09
9,2509,50010:38

Aktuelle News zur AVADEL PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoAvadel Pharmaceuticals plc: Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)4DUBLIN, July 21, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee...
► Artikel lesen
01.07.Avadel Shareholder Seeks Board Shakeup, Citing Millions Lost On Lumryz4
30.06.Avadel stock rises after appeals court upholds LUMRYZ approval4
AVADEL PHARMACEUTICALS Aktie jetzt für 0€ handeln
30.06.Investor urges Avadel shareholders to vote against directors2
30.06.Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation105DUBLIN, June 30, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced that, on Friday, June...
► Artikel lesen
30.06.Avadel Pharmaceuticals steht vor Vorstandsherausforderung durch Investor ASL Strategic Value2
30.06.Avadel Pharmaceuticals faces board challenge from investor ASL Strategic Value - report1
27.06.AVADEL PHARMACEUTICALS PLC - 8-K, Current Report2
16.06.Avadel Pharmaceuticals plc: Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)56DUBLIN, June 16, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee...
► Artikel lesen
05.06.Avadel Pharmaceuticals auf Jefferies-Konferenz: Strategisches Wachstum und Herausforderungen1
05.06.Avadel gets FDA's Orphan Drug status for sleep disorder treatment3
05.06.Avadel Pharma Says FDA Grants Orphan Drug Designation For LUMRYZ To Treat Idiopathic Hypersomnia1
05.06.FDA grants orphan drug status to Avadel's IH treatment3
05.06.Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia85DUBLIN, June 05, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that LUMRYZTM...
► Artikel lesen
05.06.AVADEL PHARMACEUTICALS PLC - 8-K, Current Report-
13.05.Avadel Pharmaceuticals appoints Susan Rodriguez as COO2
13.05.Avadel appoints new COO to boost narcolepsy drug growth3
13.05.AVADEL PHARMACEUTICALS PLC - 8-K, Current Report1
13.05.Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer223DUBLIN, May 13, 2025 (GLOBE NEWSWIRE) -- DUBLIN, May 13, 2025 - Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced...
► Artikel lesen
08.05.Avadel Pharmaceuticals plc: Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)103DUBLIN, May 08, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee...
► Artikel lesen
Weiter >>
50 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1